ESG

America's largest sugar producer is launching a fleet of autonomous tractors, a move that promises greater efficiency but also reshapes the future of farm labor.

By automating the production of a groundbreaking immune therapy, a new collaboration could finally unlock the full potential of personalized medicine for cancer.

Backed by Dongfeng and already profitable, Chinese EV brand VOYAH is charting a unique global path with production-ready tech and a disciplined strategy.

Odyssey Marine and AOMC are merging to create a deep-sea mining giant, chasing vital minerals. But can they navigate the immense financial and environmental risks?

A new partnership tackles the rising financial threat of cognitive decline, helping Canadians protect their family, finances, and future from a growing crisis.

After a multimillion-dollar overhaul, Waikiki's oldest hotel blends 125 years of history with modern luxury and deep-rooted Hawaiian culture.

Exploration reveals a multi-kilometer mineralized system at the Tipicancha target, setting the stage for a pivotal drill program amid a global copper crunch.

The fintech giant's new report reveals a major shift, tying management pay to sustainability and deploying AI to empower small businesses globally.

Anaveon reveals promising ASCO data for its cancer drug ANV600, yet puts the asset on the market to fund a bold new focus on autoimmune diseases.

As Vancouver embraces EVs and heat pumps, its older homes face a crisis. Outdated electrical systems pose fire risks and insurance woes. Are you prepared?

The specialty manufacturer reports a 46% profit surge, fueled by strong demand for its key drug and a major distributor's comeback. What's next?

Strategic Value Partners acquires Birdsboro Power, a key asset for meeting soaring electricity demand driven by AI and data centers in the PJM grid.

For the 8th straight year, Equashield dominates the CSTD market. We explore the tech, trust, and automation driving its success in protecting workers.

With backing from Shaquille O'Neal and a solid business plan, the UPSHOT League tips off May 15, aiming to reshape the landscape of women's pro basketball.

Dr. Amanda Wilson's appointment to a powerful D.C. council puts her tech-driven addiction treatment model in the national policy spotlight.

How one company turned its internal training program into a strategic powerhouse, earning a top award and creating a blueprint for the future of work.

At a top Paris expo, GUYU's biotech arm BioQ unveiled cellular anti-aging ingredients, signaling a new era of Chinese innovation in the beauty supply chain.

An innovative RNA-editing therapy for hepatocellular carcinoma has received a major FDA designation, potentially accelerating its path to patients.

A new fund, NICO, challenges ESG norms by investing in tobacco giants, aiming to force a shift to safer products. Can engagement succeed where exclusion has failed?

A three-month FDA delay for a new LEQEMBI injection highlights the high-stakes race for a convenient Alzheimer's therapy and its complex safety hurdles.